Cannara Biotech Inc. (LOVFF)
OTCMKTS · Delayed Price · Currency is USD
1.400
+0.040 (2.94%)
At close: Feb 11, 2026
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of $135.2 million as of February 12, 2026. Its market cap has increased by 96.95% in one year.
Market Cap
135.20M
Enterprise Value
148.66M
Revenue
80.34M
Ranking
n/a
PE Ratio
15.99
Stock Price
$1.40
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 159.42M to 135.20M, a decrease of -15.19%. That is a compound annual growth rate of -2.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 135.20M | 12.16% |
| Dec 31, 2025 | 120.54M | 160.36% |
| Dec 31, 2024 | 46.30M | -18.17% |
| Dec 29, 2023 | 56.58M | -8.15% |
| Dec 30, 2022 | 61.59M | -34.13% |
| Dec 31, 2021 | 93.50M | 101.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 473.68M |
| Nika Pharmaceuticals | 403.38M |
| Jushi Holdings | 105.84M |
| Growth Stalk Holdings | 77.83M |
| Sofgen Pharma | 55.75M |
| Radnostix | 44.37M |
| Earth Science Tech | 43.42M |
| Healthy Extracts | 38.47M |